InvestorsHub Logo
Followers 5
Posts 151
Boards Moderated 0
Alias Born 08/03/2015

Re: Inoviorulez post# 124619

Sunday, 04/24/2016 8:47:55 PM

Sunday, April 24, 2016 8:47:55 PM

Post# of 130502
He never saw that the CEO would switch to ESS???

ESS is Rubenfeld's baby, not Gerald's. Rubenfeld was on the board of Regenicin. He is the one pushing ESS.


Because when Rubenfield signed on board he thought the company would advance MANF, Lympro, Eltoprazine. He never saw that the CEO would switch to ESS. First of all ESS is a dermatolgoy indication what does that have to do with Neurology? Parkinson's, Alzheimer's, etc.